Healthcare Value Capital’s Standard BioTools LAB Stock Holding History

Healthcare Value Capital’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-450,000	Closed	-$3.88M	–	12
2018 Q4	$3.88M	Hold	450,000	–	–	15.08%	2
2018 Q3	$3.37M	Hold	450,000	–	–	8.15%	6
2018 Q2	$2.68M	Buy	450,000 +39,500	+10%	+$225K	7.6%	7
2018 Q1	$2.4M	Hold	410,500	–	–	9.96%	4
2017 Q4	$2.42M	Buy	410,500 +50,000	+14%	+$274K	7.35%	5
2017 Q3	$1.82M	Hold	360,500	–	–	3.64%	9
2017 Q2	$1.46M	Buy	360,500 +85,500	+31%	+$405K	2.62%	12
2017 Q1	$1.56M	Buy	+275,000	New	+$1.74M	2.68%	12

Other funds holding LAB

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Healthcare Value Capital's LAB Position: Q1 2019 in Review

Healthcare Value Capital sold out of Standard BioTools (LAB) in Q1 2019, closing a stake of 450,000 shares — an estimated $3.88M sold.

Healthcare Value Capital first reported a position in LAB in Q1 2017 and held it in 8 quarters. The position peaked at $3.88M in Q4 2018. 131 funds tracked by Wall St. Rank hold LAB as of Q1 2019.

Healthcare Value Capital reported no remaining Standard BioTools position as of Q1 2019 after selling out during the quarter.
Healthcare Value Capital sold 450,000 Standard BioTools shares in Q1 2019, an estimated $3.88M.
Healthcare Value Capital first reported a position in Standard BioTools in Q1 2017 and held it in 8 quarters.
Healthcare Value Capital's Standard BioTools position peaked at $3.88M in Q4 2018.
131 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2019.

Based on Healthcare Value Capital's 13F filing for Q1 2019, filed 14 May 2019.